Gas7 attenuates hepatocellular carcinoma progression and chemoresistance through the PI3K/Akt signaling pathway

被引:2
作者
Liu, Wen-Feng [1 ,2 ,3 ]
Zhang, Qi-Wei [4 ]
Quan, Bing [1 ,2 ]
Zhang, Feng [1 ,2 ,3 ]
Li, Miao [1 ,2 ]
Lu, Shen-Xin [1 ,2 ]
Dong, Ling [3 ,5 ]
Yin, Xin [1 ,2 ,5 ]
Liu, Bin-Bin [1 ,2 ,5 ]
机构
[1] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China
[2] Natl Clin Res Ctr Intervent Med, Shanghai 200032, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, Shanghai 200032, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Intervent Radiol, Shanghai 200025, Peoples R China
[5] 136 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China
关键词
Gas7; PI3K/Akt signaling pathway; Hepatocellular carcinoma; HEMATOPOIETIC PROGENITORS; CELL-CYCLE; PROLIFERATION; CONTRIBUTES; MIGRATION; MLL-GAS7;
D O I
10.1016/j.cellsig.2023.110908
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Growth arrest-specific gene 7 (Gas7) was involved in various cellular functions, although its specific roles and molecular mechanisms in hepatocellular carcinoma (HCC) remained unclear. So the current study was to investigate the role of Gas7 in HCC. Our findings revealed that Gas7 was downregulated in various HCC cell lines and low Gas7 expression was associated with decreased overall survival in patients with HCC. Additionally, our functional assays showed that Gas7 inhibited cell proliferation and migration, induced cell cycle arrest, apoptosis, and autophagy, and enhanced oxaliplatin sensitivity by inhibiting the PI3K/Akt signaling pathway. We also observed that transcription factor Sp1 was responsible for inhibiting Gas7. These findings provide insights into the role and elucidated a potential mechanism of Gas7 in HCC progression and metastasis. It was also observed that the Sp1/Gas7/PI3K/Akt axis was critical for malignant phenotype and oxaliplatin sensitivity in HCC. Therefore, Gas7 can be considered as a prognostic predictor and therapeutic target for HCC.
引用
收藏
页数:12
相关论文
共 50 条
[21]   MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway [J].
Zhenyu Zhang ;
Jinfeng Zhu ;
Yansong Huang ;
Weibing Li ;
Hongqiu Cheng .
Diagnostic Pathology, 13
[22]   MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway [J].
Zhang, Zhenyu ;
Zhu, Jinfeng ;
Huang, Yansong ;
Li, Weibing ;
Cheng, Hongqiu .
DIAGNOSTIC PATHOLOGY, 2018, 13
[23]   MiR-660-5p promotes the progression of hepatocellular carcinoma by interaction with YWHAH via PI3K/Akt signaling pathway [J].
Wu, Yunyu ;
Zhang, Yan ;
Wang, Feng ;
Ni, Qingfeng ;
Li, Mei .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 531 (04) :480-489
[24]   MicroRNA-4317 suppresses the progression of hepatocellular carcinoma by targeting ZNF436-mediated PI3K/AKT signaling pathway [J].
Zhang, Li ;
Chang, Shuai ;
Zhao, Yao ;
Cao, Gang ;
Zhang, Di .
TISSUE & CELL, 2022, 74
[25]   ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway [J].
Ni, Sheng ;
Wei, Qian ;
Yang, Li .
ONCOTARGETS AND THERAPY, 2020, 13 :12409-12419
[26]   TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway [J].
Fan, Ming-De ;
Zhao, Xue-Ying ;
Qi, Jian-Ni ;
Jiang, Yang ;
Liu, Bing-Yu ;
Dun, Zhi-Ping ;
Zhang, Rui ;
Wang, Cheng-Wei ;
Pang, Qi .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (02) :802-809
[27]   Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma [J].
Sun, Fengkai ;
Wang, Jianping ;
Sun, Qi ;
Li, Fanni ;
Gao, Hengjun ;
Xu, Lin ;
Zhang, Jiao ;
Sun, Xiaoyan ;
Tian, Yanan ;
Zhao, Qiujie ;
Shen, Huimin ;
Zhang, Kai ;
Liu, Jun .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (01)
[28]   GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway [J].
Wang, Yadong ;
Fang, Xiaosan ;
Xie, Hao ;
Wang, Xiaoming .
BIOCHEMICAL GENETICS, 2024, :2423-2437
[29]   CFDP1 promotes hepatocellular carcinoma progression through activating NEDD4/PTEN/PI3K/AKT signaling pathway [J].
Zhou, Yan ;
Qiu, Jiannan ;
Liu, Siyuan ;
Wang, Peng ;
Ma, Ding ;
Zhang, Guang ;
Cao, Yin ;
Hu, Lili ;
Wang, Zhongxia ;
Wu, Junhua ;
Jiang, Chunping .
CANCER MEDICINE, 2023, 12 (01) :425-444
[30]   Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway [J].
Hsieh, Yi-Hsien ;
Hsieh, Shu-Ching ;
Lee, Chien-Hsing ;
Yang, Shun-Fa ;
Cheng, Chun-Wen ;
Tang, Meng-Ju ;
Lin, Chia-Liang ;
Lin, Chu-Liang ;
Chou, Ruey-Hwang .
ONCOTARGET, 2015, 6 (33) :34859-34874